Cimerli 61314-0624-94
Generic: Ranibizumab-Eqrn
- Manufacturer
- Sandoz Inc
- Dosage Form
- Injection, Solution
- Route
- Intravitreal
- Product Type
- Human Prescription Drug
- Marketing Start
- December 12, 2024
- Listing Expires
- December 31, 2026
- Application
- BLA761165
Need to source Cimerli? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranibizumab | .3 mg/.05mL |
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]
Selected Package
61314-0624-94Selected1 VIAL, SINGLE-DOSE in 1 CARTON (61314-624-94) / .05 mL in 1 VIAL, SINGLE-DOSE